Biomedical Engineering Reference
In-Depth Information
β -Carotene 54
OH
Vitamin A 55
FIGURE 2.1
Carotenoid derivatives.
TMS ZnBr
Pd(PPh 3 ) 4 (2 mol%)
THF
81%
Br
TMS
I
Br
56
57
SCHEME 2.19
Preparation of the C4 synthon.
1. LDA
O
2. ClPO(OEt) 2
3. LDA
85%
58
59
1. Me 3 Al, Cp 2 ZrCl 2 , CH 2 Cl 2
2. ZnCl 2 , THF
1. 57 , Pd 2 (dba) 3 (2.5 mol%)
tri(2-furyl)phosphine (10 mol%)
ZnCl
2. K 2 CO 3 , MeOH
70%
61
60
SCHEME 2.20
Synthesis of the tetraenyne.
Tetraenyne
61
, on the other hand, was prepared starting from
b
-ionone
58
,
whichwas first converted to the corresponding terminal alkyne
by elimination of an
enol phosphate intermediately formed (Scheme 2.20). Carboalumination, ZnCl 2
addition, Negishi coupling, and deprotection of the trimethylsilyl group finally
yielded the desired compound
59
.
The carboalumination and transmetalation were performed on synthon
61
61
,
followed by a Negishi coupling with 0.5 equiv of
56
to provide
b
-carotene
54
(Scheme 2.21).
Compound
was also involved in the preparation vitamin A. It was first
subjected to a carboalumination reaction, followed by a metal-metal exchange with
n- BuLi and a final formylation (Scheme 2.22).
61
1. Me 3 Al, Cp 2 ZrCl 2 , CH 2 Cl 2
2. ZnCl 2 , THF
3. 56 , Pd 2 (dba) 3 (2.5 mol%)
tri(2-furyl)phosphine (10 mol%)
68%
SCHEME 2.21
61
-Carotene ( 54 )
β
Synthesis of b -carotene.
Search WWH ::




Custom Search